Patents Assigned to Merck Patents GmbH
  • Patent number: 10344145
    Abstract: The present invention relates to colored laser-markable and laser-weldable polymeric materials which are distinguished by the fact that they comprise, as absorber, at least one doped tin oxide or indium oxide having a large specific surface area.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: July 9, 2019
    Assignee: Merck Patent GmbH
    Inventors: Reinhold Rueger, Ulrich Quittmann
  • Patent number: 10343982
    Abstract: Disclosed are compounds of formula I the use of compounds of formula I in liquid crystal media and in particular to flexoelectric liquid crystal devices containing the liquid crystal media.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: July 9, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Kevin Adlem, Owain Llyr Parri
  • Publication number: 20190202851
    Abstract: The present invention relates to bi- and trinuclear metal complexes and to electronic devices, in particular organic electroluminescent devices, containing these complexes.
    Type: Application
    Filed: August 28, 2017
    Publication date: July 4, 2019
    Applicant: Merck Patent GmbH
    Inventors: Philipp Stoessel, Christian Ehrenreich, Philipp Harbach, Anna Hayer
  • Publication number: 20190204747
    Abstract: [Problem] To provide a composition, which is a reverse pattern formation composition comprising an aqueous solvent having little influence on a resist pattern, and which is excellent in flatness and filling properties after coating and has excellent etching resistance. Furthermore, a method for forming a pattern using the same is provided. [Means for Solution] A reverse pattern formation composition comprising a polysiloxane compound comprising a repeating unit having a nitrogen-containing group and a solvent comprising water, and a method for forming a fine pattern using the same.
    Type: Application
    Filed: July 3, 2017
    Publication date: July 4, 2019
    Applicant: Merck Patent GmbH
    Inventors: Xiaowei WANG, Tatsuro NAGAHARA
  • Patent number: 10336940
    Abstract: The application relates to a device for regulating the entry of light into a room, which comprises a switchable layer of specific design comprising a twisted nematic liquid-crystalline medium and a dichroic compound.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: July 2, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Michael Junge, Andreas Beyer, Ursula Patwal
  • Patent number: 10340457
    Abstract: The invention relates to novel organic semiconducting compounds, which are small molecules or conjugated polymers, containing one or more fluorinated polycyclic units, to methods for their preparation and educts or intermediates used therein, to compositions, polymer blends and formulations containing them, to the use of the compounds, compositions and polymer blends as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, organic photodetectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE, OPV, OPD, OFET and OLED devices comprising these compounds, compositions or polymer blends.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: July 2, 2019
    Assignee: Merck Patent GmbH
    Inventors: Mansoor D'Lavari, William Mitchell, Changsheng Wang, David Sparrowe
  • Publication number: 20190194344
    Abstract: The present invention provides novel peptide sequences for use in microbial transgluatminase-mediated, in particular mTG2-mediated bioconjugations, in particular for the manufacture of antibody-drug-conjugates. Further disclosed are bioconjugation methods employing mTG2 and the novel peptide sequence motifs of the invention. The present invention further provides proteins comprising the novel sequence motifs of the invention as well as polynucleotides encoding the same.
    Type: Application
    Filed: August 4, 2016
    Publication date: June 27, 2019
    Applicant: Merck Patent GmbH
    Inventors: Birgit Piater, Ulrich Betz, Harald Kolmar, Vanessa Siegmund
  • Publication number: 20190192383
    Abstract: The present invention relates to a process for the preparation of a solid pharmaceutical administration form using a 3D printing process as well. The process is a printing process that allows the production of solid pharmaceutical administration forms in a flexible manner and in conformity with the high quality standards required for the production of pharmaceuticals.
    Type: Application
    Filed: September 8, 2017
    Publication date: June 27, 2019
    Applicant: Merck Patent GmbH
    Inventors: Stefan SCHILLER, Andrea HANEFELD, Gerhard JONSCHKER
  • Patent number: 10333068
    Abstract: The present invention relates inter alia to compositions comprising conjugated polymers and a small molecule, devices comprising the composition and the application of the devices.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: June 25, 2019
    Assignee: Merck Patent GmbH
    Inventors: Junyou Pan, Herwig Buchholz, Ludvig Edman, Shi Tang
  • Patent number: 10329270
    Abstract: The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: June 25, 2019
    Assignee: Merck Patent GmbH
    Inventors: Hui Qiu, Richard D. Caldwell, Constantin Neagu, Igor Mochalkin, Lesley Liu-Bujalski, Reinaldo Jones, Devon Tate, Theresa L. Johnson, Anna Gardberg
  • Patent number: 10328423
    Abstract: The invention relates to perfluoroalkyl group-containing bismuth compounds as Lewis acid catalysts, to specific compounds, and to the method for the production thereof.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: June 25, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Berthold Theo Hoge, Sven Joerg-Ruediger August Solyntjes, Anne Julia Bader, Nikolai Ignatiev
  • Patent number: 10329297
    Abstract: The present invention relates to compounds, and pharmaceutically acceptable compositions thereof, useful as antagonists of IDO, and for the treatment of IDO-related disorders.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: June 25, 2019
    Assignee: Merck Patent GmbH
    Inventor: Brian A. Sherer
  • Publication number: 20190185480
    Abstract: The present invention relates to organic semiconducting compounds of formula (I) wherein X1 is C, Si or Ge; X2 is 0, S or Se; and X3 is N or P as well as to organic electronic devices comprising such organic semiconducting compounds.
    Type: Application
    Filed: August 8, 2017
    Publication date: June 20, 2019
    Applicant: Merck Patent GmbH
    Inventors: Daniel BECKER, Andreas TAUGERBECK, Martin SCHRAUB
  • Publication number: 20190185754
    Abstract: A liquid-crystalline media (LC media) containing a low-molecular-weight, non-polymer component, and a combination of self-alignment additives for vertical alignment of two or more of the specified kinds (formulae IA to IM). The combination of two or more self-alignment additives affect homeotropic (vertical) alignment of the LC media at a surface or the cell surfaces of a liquid-crystal display (LC display).
    Type: Application
    Filed: December 19, 2018
    Publication date: June 20, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Graziano ARCHETTI, Izumi SAITO, Rocco FORTTE, Edward Plummer, Dmitry USHAKOV, Helmut HAENSEL, Melanie KLASEN-MEMMER
  • Publication number: 20190185746
    Abstract: The present invention relates to liquid crystalline (LC) medium, to a method of its production and to the use of such LC media in polymer network liquid crystalline (PNLC) light modulation elements operated in the normally transparent mode. Furthermore, the present invention relates to such light modulation elements, as such, to the use of such light modulation elements as light shutters for transparent OLED displays, to the use of such light modulation elements in smart windows, and to a method of production of such light modulation elements according to the present invention.
    Type: Application
    Filed: September 4, 2017
    Publication date: June 20, 2019
    Applicant: Merck Patent GmbH
    Inventors: Dong-Mee SONG, Hyun-Woo BAE, Jung-Min LEE, Yong-Kuk YUN
  • Publication number: 20190185747
    Abstract: The present invention relates to liquid-crystalline media comprising one or more compounds of formula Q and one or more compounds selected from the group of compounds of formulae T, U and I wherein the occurring groups and parameters have the meaning indicated in claim 1. The present invention further relates to the use of these liquid-crystal media, in particular in components for high-frequency technology, and to components of this type which contain media according to the invention, and to the production and use of these components. The components according to the invention are suitable, in particular, as phase shifters in the microwave and millimetre wave region, for microwave and millimetre wave array antennae and very particularly for so-called tunable “reflectarrays”.
    Type: Application
    Filed: August 22, 2017
    Publication date: June 20, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Michael WITTEK, Renate SEEGER
  • Publication number: 20190189925
    Abstract: The invention relates to novel organic semiconducting (OSC) compounds containing one or more 1,3-dithiolo[5,6-f]benzo-2,1,3-thiadiazole (“DTBTz”) or 1,3-dithiolo[6,7-g]quinoxaline (“DTQ”) units or derivatives thereof, to methods for their preparation and educts or intermediates used therein, to compositions and formulations containing them, to the use of the compounds and compositions as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, perovskite-based solar cell (PSC) devices, organic photodetectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE devices comprising these compounds or compositions.
    Type: Application
    Filed: August 28, 2017
    Publication date: June 20, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Changsheng WANG, William MITCHELL
  • Publication number: 20190189698
    Abstract: The present invention relates inter alia to a color display comprising nanoparticles and color filters.
    Type: Application
    Filed: February 14, 2019
    Publication date: June 20, 2019
    Applicants: MERCK PATENT GMBH, YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD.
    Inventors: Bernhard RIEGER, Edgar BOEHM, Volker HILARIUS, Christof PFLUMM, Uri BANIN
  • Publication number: 20190185748
    Abstract: The present invention relates to an LC medium comprising and a liquid-crystalline host consisting of an LC component H) comprising one or more mesogenic or liquid-crystalline compounds and an optically active component D) and optionally a polymerizable component P) comprising one or more polymerizable compounds; and to the use of the polymerizable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the polymer sustained alignment type.
    Type: Application
    Filed: December 19, 2018
    Publication date: June 20, 2019
    Applicant: MERCK PATENT GMBH
    Inventor: Kirsten (Min-Chu) LIAO
  • Patent number: 10323188
    Abstract: The present invention relates to liquid-crystalline media comprising one or more pleochroic dyes and one or more compounds selected from the group of compounds of formulae I, II and III, in which the parameters have the meaning indicated in Claim 1, and to components comprising these media for high-frequency technology, in particular phase shifters and microwave array antennas.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: June 18, 2019
    Assignee: Merck Patent GmbH
    Inventors: Michael Wittek, Dagmar Klass, Peer Kirsch